Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by floatinketucky


V.TLT

RE:RE:RE:TRIAL DATA RESULTS

Just wanted to add my .02 cents.  I agree the trial information is NOT...

October 25, 2021

V.TLT

Maybe we have already seen the bottom.

I don't know. 

October 22, 2021

V.TLT

RE:$TLTFF - .3424 Historical Price Recovery from these levels.

{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com...

October 20, 2021

V.TLT

$TLTFF - .3424 Historical Price Recovery from these levels.

10 year Monthly.

October 20, 2021

V.TLT

Recovery from Sept 20 2021

Maybe.... Starting to look lke a baby uptrend. 

October 18, 2021

V.TLT

TLTFF - Debt free baby!!!!

That's right players!!!{^youtubevideo|(width)425|(height)264|(rel)False...

September 14, 2021

V.TLT

RE:The thing is...

On the comparison with Merck’s Keytruda, which has been approved for BCG...

September 14, 2021

V.TLT

The thing is...

This board is about the science of TLTFF. It's not about the people on...

September 14, 2021

V.TLT

RE:potential Breakthrough Designation Approval

$TLTFFOn the preliminary results, Theralase said, “The current interim...

September 13, 2021

V.TLT

potential Breakthrough Designation Approval

$TLTFF-25 patients for potential Breakthrough Designation Approval-2021...

September 13, 2021

V.TLT

My .02 cents on the newsletter.

Look back at the history of when the newsletter came out. It's all over...

September 11, 2021

V.TLT

TLTFF- In good standing to challenge Merck’s Keytruda.

    Research Capital analyst Andr Uddin is sticking with his...

September 11, 2021

V.TLT

RE:RE:Note to self

hey care to elaborate?  727K and make that rat squirm

September 9, 2021

V.TLT

Playin guitar for a tonner??

Hey ya'll? Do ya'll recall a few years back when that guy set up a...

September 9, 2021

V.TLT

RE:RE:RE:RE:Interim Financials

Shawn Shirazi PhD, Chief Executive Officer, Theralase®, stated, "It...

May 30, 2021

V.TLT

RE:RE:RE:Interim Financials

I think the trial is going great. The CEO is involed with scheduling...

May 30, 2021

V.TLT

RE:RE:TLC-2000 Recall finally terminated

floatinketucky wrote: Eoganacht wrote: As of Dec. 3 2020 https...

May 28, 2021

V.TLT

2021 monthly cash burn rate 306,364.

The net loss for the three-month period ended March 31, 2021, was $919,093...

May 28, 2021

V.TLT

Honestly. Look to the science.

EOM.

May 7, 2021

V.TLT

Study II Preliminary Data-includes three patients study Ib

Study II Preliminary Clinical Data To date, the phase II NMIBC clinical...

May 6, 2021